Tempus
Tempus is a precision oncology platform that combines genomic sequencing, AI-driven data analysis, and clinical trial matching to help oncologists make molecularly informed treatment decisions. With over 30 million de-identified patient records, Tempus connects molecular profiling to real-world outcomes and matches patients to relevant clinical trials.
Direct Answer
Tempus is covered because Tempus appears in our clinical AI review database. Tempus is rated 4.4/5, with pricing listed as Enterprise / Institutional. Use this page to connect the company entity to its reviewed products, headquarters, founding details, and external profiles.
Source: Clinical AI Report, 2026